Creo Medical Group (CREO) RNS Announcements

Add to Alert list
Date Time Source Announcement
06 Jul 2023 11:33 AM
RNS
Issue of Equity and TVR
27 Jun 2023 01:15 PM
RNS
Result of AGM
27 Jun 2023 07:00 AM
RNS
AGM Statement & Directorate Succession Planning
26 Jun 2023 07:00 AM
RNS
First upper GI Speedboat procedure in Europe
22 Jun 2023 07:00 AM
RNS
Appointment of Marco Scarci
19 Jun 2023 07:00 AM
RNS
Speedboat Inject upper GI clearance in Europe
01 Jun 2023 07:00 AM
RNS
Speedboat™ Inject selected by NICE for assessment
26 May 2023 07:00 AM
RNS
Posting of Annual Report and Notice of AGM
23 May 2023 07:00 AM
RNS
First in-human milestone for MicroBlate™ Flex
17 May 2023 07:00 AM
RNS
Royal Oldham Hospital Agreement
15 May 2023 07:00 AM
RNS
Attendance at Digestive Disease Week
26 Apr 2023 07:00 AM
RNS
Final Results
14 Apr 2023 07:00 AM
RNS
Albyn Medical earn out update
31 Mar 2023 10:45 AM
RNS
Total Voting Rights
31 Mar 2023 07:00 AM
RNS
MicroBlateT Flex clinical study
13 Mar 2023 06:13 PM
RNS
Director/PDMR and PCA Share Dealings
13 Mar 2023 07:00 AM
RNS
Holding(s) in Company
08 Mar 2023 10:25 AM
RNS
Result of GM
06 Mar 2023 11:05 AM
RNS
Second Price Monitoring Extn
06 Mar 2023 11:00 AM
RNS
Price Monitoring Extension
21 Feb 2023 10:29 AM
RNS
Holding(s) in Company
17 Feb 2023 02:05 PM
RNS
Second Price Monitoring Extn
17 Feb 2023 02:00 PM
RNS
Price Monitoring Extension
17 Feb 2023 12:10 PM
RNS
Launch of Open Offer and Posting of Circular
16 Feb 2023 06:04 PM
RNS
Result of Placing and Subscription
16 Feb 2023 09:05 AM
RNS
Second Price Monitoring Extn
16 Feb 2023 09:00 AM
RNS
Price Monitoring Extension
16 Feb 2023 07:00 AM
RNS
Placing and Subscription to raise a minimum £25m
15 Feb 2023 11:05 AM
RNS
Second Price Monitoring Extn
15 Feb 2023 11:00 AM
RNS
Price Monitoring Extension
30 Jan 2023 08:51 AM
RNS
Award of Shares under Share Incentive Plan
23 Jan 2023 11:47 AM
EQS
Creo Medical (CREO): Progressing on all fronts
18 Jan 2023 02:05 PM
RNS
Second Price Monitoring Extn
18 Jan 2023 02:00 PM
RNS
Price Monitoring Extension
11 Jan 2023 07:00 AM
RNS
FY 2022 Trading Update
16 Dec 2022 02:05 PM
RNS
Second Price Monitoring Extn
16 Dec 2022 02:00 PM
RNS
Price Monitoring Extension
01 Dec 2022 02:12 PM
RNS
Holding(s) in Company
24 Oct 2022 07:00 AM
RNS
Kamaptive Licence and Royalty Agreement with CMR
30 Sep 2022 07:00 AM
RNS
Total Voting Rights
23 Sep 2022 07:00 AM
RNS
Exercise of Options
22 Sep 2022 07:00 AM
RNS
Chris Hancock elected as a Fellow of Royal Academy
09 Sep 2022 07:00 AM
RNS
Half-year Report
05 Sep 2022 07:00 AM
RNS
Notice of Results
31 Aug 2022 07:00 AM
RNS
Total Voting Rights
08 Aug 2022 07:00 AM
RNS
LTIP Awards and PDMR Dealing
04 Aug 2022 07:00 AM
RNS
Exercise of Options
03 Aug 2022 07:00 AM
RNS
H1 2022 Trading Update
02 Aug 2022 07:00 AM
RNS
Award of Shares under Share Incentive Plan
28 Jun 2022 12:33 PM
RNS
Result of AGM

Creo Medical Group PLC is a medical device company that develops and sells minimally invasive electrosurgical devices for surgical endoscopy.

Creo Medical's technology includes the CROMA, which uses bipolar radiofrequency and high frequency microwave energy for cutting and coagulation. The company also has a proprietary energy technology called Kamaptive, which adapts to the tissue environment.

Creo Medical Group is listed on the London Stock Exchange under the ticker CREO.

CREO share price launched at 77p in 2016.

UK 100

Latest directors dealings